je.st
news
Home
› Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The U.S. Food And Drug Administration (FDA)
Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The U.S. Food And Drug Administration (FDA)
2015-03-04 02:40:12| drugdiscoveryonline Home Page
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel central nervous system (CNS) and pain therapies, and its commercial and development partner, Zambon S.p.A., an international pharmaceutical company, announced recently that the New Drug Application (NDA) for Xadago (safinamide) has been accepted for filing by the U.S. Food and Drug Administration (FDA)
Tags: food
application
administration
accepted
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||